Enzastaurin and aspartate aminotransferase increased Patient Reports February 09, 2012

Enzastaurin Side Effects Report #5875674-9
Enzastaurin side effect was reported by a Physician from JAPAN on Aug 27, 2008. Male patient, weighting 182.1 lb, was diagnosed with non-small cell lung cancer and was treated with Enzastaurin. After drug was administered, patient experienced the following side effects: alanine aminotransferase increased, aspartate aminotransferase increased. Enzastaurin dosage: 1125 MG, OTHER. During the same period patient was treated with PEMETREXED, HYDROXOCOBALAMIN ACETATE, VITAMIN, AMLODIPINE BESYLATE, LIPITOR, CLARITIN. Patient was hospitalized. Patient recovered.